European Organization for Caries Research Workshop: Methodology for Determination of Potentially Available Fluoride in Toothpastes.

Available Fluoride Fluoride Fluoride Analysis Research Workshop Toothpastes

Journal

Caries research
ISSN: 1421-976X
Titre abrégé: Caries Res
Pays: Switzerland
ID NLM: 0103374

Informations de publication

Date de publication:
2019
Historique:
received: 28 03 2018
accepted: 28 03 2018
pubmed: 25 7 2018
medline: 18 12 2019
entrez: 25 7 2018
Statut: ppublish

Résumé

Toothpastes are the most universally accepted form of fluoride delivery for caries prevention. To provide anti-caries benefits, they must be able to release fluoride during the time of tooth brushing or post brushing into the oral cavity. However, there is no standard accepted procedure to measure how much fluoride in a toothpaste may be (bio) available for release. The European Organization for Caries Research proposed and supported a workshop with experts in fluoride analysis in toothpastes and representatives from industry. The objective of the workshop was to discuss issues surrounding fluoride analysis in toothpaste and reach consensus on terminology and best practices, wherever the available evidence allowed it. Participants received a background paper and heard presentations followed by structured discussion to define the problem. The group also reviewed evidence on the validity, reliability and feasibility of each technique (namely chromatography and fluoride electroanalysis) and discussed their strengths and limitations. Participants were able to reach a consensus on terminology and were also able to identify and summarize the advantages and disadvantages of each technique. However, they agreed that most currently available methods were developed for regulatory agencies several decades ago, utilizing the best available data from clinical trials then, but require to be updated. They also agreed that although significant advances to our understanding of the mechanism of action of fluoride in toothpaste have been achieved over the past 4 decades, this clearly is an extraordinarily complex subject and more work remains to be done.

Identifiants

pubmed: 30041245
pii: 000490196
doi: 10.1159/000490196
doi:

Substances chimiques

Cariostatic Agents 0
Toothpastes 0
Fluorides Q80VPU408O

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

119-136

Informations de copyright

© 2018 S. Karger AG, Basel.

Auteurs

E Angeles Martinez-Mier (EA)

Department of Cariology, Operative Dentistry and Dental Public Health, Indiana University School of Dentistry, Indianapolis, Indiana, USAesmartin@iu.edu.

Livia Maria Andaló Tenuta (LMA)

Department of Cariology, Restorative Sciences and Endodontics, School of Dentistry, University of Michigan, Ann Arbor, Michigan, USA.

Clifton M Carey (CM)

Department of Craniofacial Biology, School of Dental Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Jaime A Cury (JA)

Department of Physiological Sciences, Piracicaba Dental School, UNICAMP, Piracicaba, Brazil.

Cor van Loveren (C)

Department of Preventive Dentistry, Academic Centre for Dentistry Amsterdam, University of Amsterdam and Vrije Universiteit, Amsterdam, The Netherlands.

Kim Rud Ekstrand (KR)

Department of Odontology, University of Copenhagen, Copenhagen, Denmark.

Carolina Ganss (C)

Department of Conservative and Preventive Dentistry, Justus Liebig University, Giessen, Germany.

Andreas Schulte (A)

Department of Special Care Dentistry, University of Witten/Herdecke, Witten, Germany.

Arif Baig (A)

Health Care Research Center, The Procter and Gamble Company, Mason, Ohio, USA.

Habib Benzian (H)

Department of Epidemiology and Health Promotion, New York University College of Dentistry, New York, New York, USA.

Peter Bottenberg (P)

Oral Health Research Group, Vrije Universiteit Brussel, Brussels, Belgium.

Mark J Buijs (MJ)

Department of Preventive Dentistry, Academic Centre for Dentistry Amsterdam, University of Amsterdam and Vrije Universiteit, Amsterdam, The Netherlands.

Alan Ceresa (A)

Colgate-Palmolive Europe, Therwil, Switzerland.

Joana Christina Carvalho (JC)

Faculty of Medicine and Dentistry, Catholic University of Louvain, Brussels, Belgium.

Roger Ellwood (R)

University of Manchester, Colgate Palmolive Dental Health Unit, Manchester, United Kingdom.

Carlos González-Cabezas (C)

Department of Cariology, Restorative Sciences and Endodontics, School of Dentistry, University of Michigan, Ann Arbor, Michigan, USA.

Christopher Holmgren (C)

Aide Odontologique Internationale, Montrouge, France.

Michael Knapp (M)

Oral Health Research Group, Vrije Universiteit Brussel, Brussels, Belgium.

Frank Lippert (F)

Department of Cariology, Operative Dentistry and Dental Public Health, Indiana University School of Dentistry, Indianapolis, Indiana, USA.

Andrew Joiner (A)

Unilever Oral Care, Bebington, Wirral, United Kingdom.

David J Manton (DJ)

Melbourne Dental School, University of Melbourne, Carlton, Victoria, Australia.

Stefania Martignon (S)

UNICA Caries Research Unit, Research Vice-rectory, Universidad El Bosque, Bogotá, Colombia.
Dental Innovation and Translation Centre, King's College Dental Institute, London, United Kingdom.

Stephen Mason (S)

GlaxoSmithKline Consumer Healthcare, Weybridge, Surrey, United Kingdom.

Anahita Jablonski-Momeni (A)

Department of Pediatric and Community Dentistry, Philipps University, Marburg, Germany.

Walter Plett (W)

Department of Conservative Dentistry, University of Heidelberg, Heidelberg, Germany.

Chris Rahiotis (C)

Department of Operative Dentistry, Faculty of Dentistry, National and Kapodistrian University of Athens, Athens, Greece.

Fábio Sampaio (F)

Universidade Federal da Paraíba, Centro de Ciências da Saúde, João Pessoa, Paraíba, Brazil.

Domenick T Zero (DT)

Department of Cariology, Operative Dentistry and Dental Public Health, Indiana University School of Dentistry, Indianapolis, Indiana, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH